FEMOSTON ^®

Femoston is a prescription medication that comes in two forms: Femoston Conti and Conti-Low, or Femoston 1/10mg and 2/10mg. Both versions of Femoston are combined hormone replacement therapy (HRT) that contain oestrogen and progesterone, which mimic the female sex hormones. These hormones help alleviate symptoms of menopause.

There are numerous HRT options to choose from, but the ideal choice is typically one that offers effective symptom relief while minimizing risks. In most cases, an oestrogen patch, gel, or spray is considered the optimal option. However, if you still have your womb, it is recommended to take it in combination with some form of progesterone.

The safest natural female HRT options are bioidentical hormone replacement therapy and traditional natural hormone replacement therapy. Bioidentical hormone replacement therapy is derived from plants and is chemically identical to the hormones produced by our bodies.

In fact, HRT has the potential to prevent the accumulation of abdominal fat. It is also expected to enhance sleep and alleviate other menopausal symptoms, thereby providing more energy and motivation to engage in healthy eating and exercise. One approach is to consume smaller portions, as our bodies require less food than they did before.

Utrogestan, a micronised progesterone commonly used in hormone replacement therapy (HRT) by women, has a natural sedative effect. It is typically taken at night, which can be beneficial for those experiencing difficulty sleeping as it may induce drowsiness.

There is limited evidence suggesting that most forms of HRT contribute to weight gain. However, it is common to experience weight gain during menopause and as you age, regardless of whether you are on HRT or not. To manage your weight, it is recommended to engage in regular exercise and maintain a balanced diet.

However, what do these terms actually signify? And, more importantly, which one should you opt for? The most secure and closely monitored form of hormone replacement therapy (HRT) is body identical HRT, which is also prescribed by the NHS. This type of HRT involves using oestrogen patches, gels, or sprays that are applied to the skin, as well as micronised progesterone, commonly referred to as Utrogestan in the UK.

Femoston-conti tablets contain 1 mg estradiol (as hemihydrate) and 5 mg dydrogesterone. Femoston tablets contain either 1 mg estradiol (as hemihydrate) or a combination of 1 mg estradiol (as hemihydrate) and 10 mg dydrogesterone.

Femoston Conti includes weight changes as a potential side effect, but it is unclear whether HRT or menopause is directly responsible for this.

Exceeding the recommended dosage of Femoston-conti may result in symptoms such as nausea, vomiting, breast tenderness or pain, dizziness, abdominal pain, drowsiness, or withdrawal bleeding.

If you have recently started HRT and are noticing weight gain, it is possible that this could be due to water retention. It is common for women to experience initial water retention during the first few months of HRT treatment. However, it is important to note that we cannot definitively say whether or not HRT is directly causing the weight gain.

While there is no scientific evidence to directly support the claim that Hormone Replacement Therapy (HRT) causes weight loss, many women report feeling better overall when using HRT.

The possible side effects of Femoston that are common (affecting between 1 in 10 and 1 in 100 individuals) include vaginal thrush, mood changes such as depression, anxiety, irritability, and migraine.

If you’re experiencing symptoms of menopause and are looking to lose weight, hormone replacement therapy (HRT) can be beneficial in multiple ways. Numerous studies have shown that menopausal HRT can significantly affect weight loss, as well as the amount of fat your body stores and its distribution.

If you have any concerns about breast tenderness and growth as a side effect of your hormone therapy, please discuss them with your doctor. HRT contains hormones that can stimulate breast tissue, leading to these effects.

Despite concerns about weight gain, there is no scientific evidence to support the idea that Hormone Replacement Therapy (HRT) causes weight gain in women. While a small number of women may experience fluid retention with HRT, resulting in a potential weight gain of up to 10 pounds in a month, this is typically a mild side effect that will normalize within a month or two.

We all desire immediate results, but it is important to understand that the benefits of HRT require some time. Although some individuals may experience improvements in sleep or mood shortly after starting HRT, changes such as enhanced muscle mass or fat loss typically require a minimum of three to six months.

If you are experiencing tiredness due to menopause, HRT can help improve it. When hot sweats disturb your sleep, starting treatment can enhance your sleep quality, leading to increased energy levels the next day.

FEMOSTON is a form of hormone replacement therapy (HRT) that aids in alleviating the discomfort experienced by women during and after menopause. Additionally, it serves to prevent the weakening of bones (osteoporosis) that can lead to fractures.

This form of hormone replacement therapy (HRT) is better suited for women who are experiencing irregular periods, as it typically leads to a monthly menstrual bleed towards the end of the dydrogesterone treatment.

The results of this study support the effectiveness of Femoston hormone replacement therapy in regulating blood clotting and promoting a favorable lipoprotein profile. This is significant in reducing the likelihood of vascular diseases in women going through menopause or who have already gone through it.

You may experience symptoms such as nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue, and withdrawal bleeding. These symptoms do not require treatment, but if you are concerned, it is recommended to consult your doctor for guidance.

The withdrawal bleeding typically began on the final day of the progestogen phase pill. Approximately 10% of women experienced break-through bleeding and/or spotting, while 21-25% of women experienced amenorrhoea (no bleeding or spotting) during months 10 to 12 of treatment.

Please note that not all women using Femoston-conti will experience these side effects, but some may experience gut disturbances such as nausea, vomiting, abdominal pain, bloating, flatulence, and indigestion.

You can find continuous combined HRT tablets or capsules under the brands Elleste Duet Conti, Kliofem, Kliovance, Femoston-conti, Indivina, and Bijuve. Take one tablet or capsule daily at the same time each day, and swallow it whole with a drink of water.

Hormone replacement therapy (HRT) is a treatment that can alleviate menopause symptoms by replenishing the declining levels of oestrogen and progesterone. One of the symptoms that HRT can effectively address is hot flushes.

However, the active ingredients in Femoston differ slightly from those in Elleste Duet. While both contain estradiol as the oestrogen supplement, Femoston uses dydrogesterone as the progesterone supplement instead of norethisterone.

If you are experiencing tiredness due to menopause, HRT can help improve it. When hot sweats disturb your sleep, starting treatment can enhance your sleep quality, leading to increased energy levels the next day.

Continuous combined hormone replacement therapy (HRT) is a medication that is prescribed to alleviate symptoms of menopause such as hot flushes, mood swings, and vaginal dryness. Some brand names for this type of HRT include Evorel Conti, Kliovance, Kliofem, Femoston Conti, and FemSeven Conti.

While some women may experience changes within a few days, most will see a gradual improvement over the course of weeks and months. Physical symptoms such as hot flushes and night sweats may improve first, typically within 4-6 weeks of being on the correct dose of estrogen.

The gold standard treatment for menopausal symptoms is oestrogen therapy, which has been found to be effective in 90% of women experiencing hot flushes.

If you have not had a period for 1 year, it is typically recommended to use continuous combined HRT, which involves taking oestrogen and progestogen every day without any breaks.

The current evidence strongly supports the use of transdermal or transvaginal estradiol therapy as the initial treatment option for young women with premature ovarian insufficiency (POI) or early menopause. It is crucial for these women to receive long-term replacement of ovarian sex steroids, with some needing this therapy for many years.

There is limited evidence suggesting that most forms of HRT contribute to weight gain. However, it is common to experience weight gain during menopause and as you age, regardless of whether you are on HRT or not. To manage your weight, it is recommended to engage in regular exercise and maintain a balanced diet.

Some women may experience weight loss when using HRT as it can restore their metabolism to a pre-menopausal state. However, progesterone may cause fluid retention, which can be mistaken for weight gain. Adjustments to the treatment plan can help minimize this effect.